241 related articles for article (PubMed ID: 22796692)
21. Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.
Rudd E; Göransdotter Ericson K; Zheng C; Uysal Z; Ozkan A; Gürgey A; Fadeel B; Nordenskjöld M; Henter JI
J Med Genet; 2006 Apr; 43(4):e14. PubMed ID: 16582076
[TBL] [Abstract][Full Text] [Related]
22. An N-Terminal Missense Mutation in STX11 Causative of FHL4 Abrogates Syntaxin-11 Binding to Munc18-2.
Müller ML; Chiang SC; Meeths M; Tesi B; Entesarian M; Nilsson D; Wood SM; Nordenskjöld M; Henter JI; Naqvi A; Bryceson YT
Front Immunol; 2014 Jan; 4():515. PubMed ID: 24459464
[TBL] [Abstract][Full Text] [Related]
23. The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India.
Shabrish S; Kelkar M; Yadav RM; Bargir UA; Gupta M; Dalvi A; Aluri J; Kulkarni M; Shinde S; Sawant-Desai S; Kambli P; Hule G; Setia P; Jodhawat N; Gaikwad P; Dhawale A; Nambiar N; Gowri V; Pandrowala A; Taur P; Raj R; Uppuluri R; Sharma R; Kini P; Sivasankaran M; Munirathnam D; Vedam R; Vignesh P; Banday A; Rawat A; Aggarwal A; Poddar U; Girish M; Chaudhary A; Sampagar A; Jayaraman D; Chaudhary N; Shah N; Jijina F; Chandrakla S; Kanakia S; Arora B; Sen S; Lokeshwar M; Desai M; Madkaikar M
Front Immunol; 2021; 12():612583. PubMed ID: 33746956
[TBL] [Abstract][Full Text] [Related]
24. Familial hemophagocytic lymphohistiocytosis type 5 in a Chinese Tibetan patient caused by a novel compound heterozygous mutation in STXBP2.
Tang X; Guo X; Li Q; Huang Z
Medicine (Baltimore); 2019 Oct; 98(43):e17674. PubMed ID: 31651895
[TBL] [Abstract][Full Text] [Related]
25. Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations.
Zhao XW; Gazendam RP; Drewniak A; van Houdt M; Tool AT; van Hamme JL; Kustiawan I; Meijer AB; Janssen H; Russell DG; van de Corput L; Tesselaar K; Boelens JJ; Kuhnle I; Van Der Werff Ten Bosch J; Kuijpers TW; van den Berg TK
Blood; 2013 Jul; 122(1):109-11. PubMed ID: 23687090
[TBL] [Abstract][Full Text] [Related]
26. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.
Rohr J; Beutel K; Maul-Pavicic A; Vraetz T; Thiel J; Warnatz K; Bondzio I; Gross-Wieltsch U; Schündeln M; Schütz B; Woessmann W; Groll AH; Strahm B; Pagel J; Speckmann C; Janka G; Griffiths G; Schwarz K; zur Stadt U; Ehl S
Haematologica; 2010 Dec; 95(12):2080-7. PubMed ID: 20823128
[TBL] [Abstract][Full Text] [Related]
27. Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis.
Viñas-Giménez L; Rincón R; Colobran R; de la Cruz X; Celis VP; Dapena JL; Alsina L; Sayós J; Martínez-Gallo M
Front Immunol; 2021; 12():723836. PubMed ID: 34630398
[TBL] [Abstract][Full Text] [Related]
28. A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis.
Bordbar MR; Modarresi F; Farazi Fard MA; Dastsooz H; Shakib Azad N; Faghihi MA
BMC Med Genet; 2017 May; 18(1):49. PubMed ID: 28468610
[TBL] [Abstract][Full Text] [Related]
29. Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: Molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP.
Chen X; Wang F; Zhang Y; Teng W; Wang M; Nie D; Zhou X; Wang D; Zhao H; Zhu P; Liu H
Clin Genet; 2018 Aug; 94(2):200-212. PubMed ID: 29665027
[TBL] [Abstract][Full Text] [Related]
30. Angeborene hämophagozytische Lymphohistiozytose (HLH).
Pachlopnik Schmid J; de Saint Basile G
Klin Padiatr; 2010 Nov; 222(6):345-50. PubMed ID: 20458667
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity.
Viñas-Giménez L; Donadeu L; Alsina L; Rincón R; de la Campa EÁ; Esteve-Sole A; Català A; Colobran R; de la Cruz X; Sayós J; Martínez-Gallo M
Int J Hematol; 2020 Mar; 111(3):440-450. PubMed ID: 31865540
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Genetic Analysis of Nine Suspected Familial Haemophagocytic Lymphohistiocytosis Patients for MUNC13-4 Deficiency and Introducing Four Novel Mutations in UNC13D.
Vahidi M; Badalzadeh M; Jannesar M; Mazinani M; Fazlollahi MR; Khodayari Namini N; Houshmand M; Hamidieh AA; Moradi L; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):487-492. PubMed ID: 32245292
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2.
Meeths M; Entesarian M; Al-Herz W; Chiang SC; Wood SM; Al-Ateeqi W; Almazan F; Boelens JJ; Hasle H; Ifversen M; Lund B; van den Berg JM; Gustafsson B; Hjelmqvist H; Nordenskjöld M; Bryceson YT; Henter JI
Blood; 2010 Oct; 116(15):2635-43. PubMed ID: 20558610
[TBL] [Abstract][Full Text] [Related]
34. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea.
Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ;
Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437
[TBL] [Abstract][Full Text] [Related]
35. Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding.
Cetica V; Hackmann Y; Grieve S; Sieni E; Ciambotti B; Coniglio ML; Pende D; Gilmour K; Romagnoli P; Griffiths GM; Aricò M
J Allergy Clin Immunol; 2015 May; 135(5):1310-8.e1. PubMed ID: 25312756
[TBL] [Abstract][Full Text] [Related]
36. A cell-based functional assay that accurately links genotype to phenotype in familial HLH.
Noori T; Rudd-Schmidt JA; Kane A; Frith K; Gray PE; Hu H; Hsu D; Chung CWT; Hodel AW; Trapani JA; Voskoboinik I
Blood; 2023 May; 141(19):2330-2342. PubMed ID: 36706356
[TBL] [Abstract][Full Text] [Related]
37. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D.
Meeths M; Chiang SC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjöld E; Björklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist BM; Rajic L; Pfeifer S; Rosthøj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI; Bryceson YT
Blood; 2011 Nov; 118(22):5783-93. PubMed ID: 21931115
[TBL] [Abstract][Full Text] [Related]
38. STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America.
Marsh RA; Satake N; Biroschak J; Jacobs T; Johnson J; Jordan MB; Bleesing JJ; Filipovich AH; Zhang K
Pediatr Blood Cancer; 2010 Jul; 55(1):134-40. PubMed ID: 20486178
[TBL] [Abstract][Full Text] [Related]
39. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
[TBL] [Abstract][Full Text] [Related]
40. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).
Pagel J; Beutel K; Lehmberg K; Koch F; Maul-Pavicic A; Rohlfs AK; Al-Jefri A; Beier R; Bomme Ousager L; Ehlert K; Gross-Wieltsch U; Jorch N; Kremens B; Pekrun A; Sparber-Sauer M; Mejstrikova E; Wawer A; Ehl S; zur Stadt U; Janka G
Blood; 2012 Jun; 119(25):6016-24. PubMed ID: 22451424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
